Although seroprevalence is declining, a significant proportion of Europe s population
is infected with HSV-2. HSV-2 accounts for approximately one-fifth of GUD cases and
two-thirds of genital herpes cases. Findings support the need to invest in HSV-2 vaccine
development, and sexual and reproductive health services.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker s bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check No potential conflicts of interest in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.